Securities code: China Reform Health Management And Services Group Co.Ltd(000503) securities abbreviation: China Reform Health Management And Services Group Co.Ltd(000503) China Reform Health Management And Services Group Co.Ltd(000503)
Record of investor relations activities
No.: 202201
□ specific object research □ analyst meeting
Investor relations □ media interview √ performance briefing
Activity category □ press conference □ Roadshow
□ site visit
□ others ()
News media unit:
China enterprise daily, China Daily, Hexun, world wide web, china.com, science and technology daily, investment community, financial community, China report, china.com, CPPCC news, china.com, economic reference network, China Financial Times, China economic times, beiqing.com, China economic guide, consumption daily, consumption times and China business daily.
Institutional and individual investors:
Northeast Securities Co.Ltd(000686) Wang Fenghua, Wang Lu China Galaxy Securities Co.Ltd(601881) international Yin Zhao; Shang Wei and Cao Yang of Everbright financial holding; Name of participant and Cui Xuemei of kailian capital; Gu Xiujuan, Beijing building materials; Hua Tai Bai Rui fund Du Cong Huatai Securities Co.Ltd(601688) fan’s name and product; Huadian capital Fan Jun; Juncheng investment Liu Tian Guotai Junan Securities Co.Ltd(601211) Li Xuewei; Tianjin yiquansun Institute; Hongding wealth Li Xianming; Dedian investment youyixiang; Fang Tengsheng, Da Yang Jijun; Mulan capital Liu Xueping; Fengjing capital Feng Feiyang; Sun Shuo of TEDA Manulife fund; Li Wan, a frontline hedge investment enterprise in Qianhai, Shenzhen; Shenzhen Shanshi fund Shi Kai; Hunan xianghongrong investment Liao Jiamin; ZHAOYOU investment Wu Zixuan Shenwan Hongyuan Group Co.Ltd(000166) Hong Yizhen; Yang Yue of Fuhui company Caitong Securities Co.Ltd(601108) sun yewei; Xiling capital Zhang Bin; Qingdao Haier Zhang Jingzhou, capital Internet, Jinyu asset management, yuntu capital and other institutional investors as well as individual investors.
Time: 15:30-16:30, May 18, 2022
Meeting mode: teleconference
Place: Yang Dianzhong, party secretary and chairman of the board of directors of the listed company
Member name: Li Yonghua, deputy secretary of the Party committee, director and general manager of the company
Liu Yingjie, member of the Party committee, director and Deputy General Manager
Independent director Wang Xiuli
Sun Liqun, member of the Party committee and Deputy General Manager
Wang Wenchang, member of the Party committee and chief accountant
Zhang Zhenhua, member of the Party committee and general manager of Medical Insurance Division
Secretary of the board of directors Liu Xinxing
1、 The company’s operation and future work prospects in 2021
Li Yonghua, general manager of China Reform Health Management And Services Group Co.Ltd(000503) (hereinafter referred to as ” China Reform Health Management And Services Group Co.Ltd(000503) ” or “the company”), gave a comprehensive introduction to the operation in 2021 and looked forward to the future work around the company’s strategic planning.
2、 Introduction to the company’s financial data
Wang Wenchang, the chief accountant of the company, reported the financial data of 2021.
3、 Interactive communication link
（1） In 2021 China Reform Health Management And Services Group Co.Ltd(000503) achieved steady growth in performance. We know that in the past two years, the national policy on fund supervision, medical insurance reform and payment method reform has been continuously strengthened, and the DRG, dip and APG businesses of Guoxin health have been fully developed. How does the company ensure its leading position in the industry?
A: 2021 is the first year of the 14th five year plan. In order to thoroughly implement the outline of the national 14th five year plan for investor relations activities and the opinions of the CPC Central Committee and the State Council on deepening the reform of the medical security system, and to comprehensively promote the construction of healthy China and Digital China, a number of policies and measures have been introduced in relevant fields to lay out the layout for the development of health security.
China Reform Health Management And Services Group Co.Ltd(000503) closely focusing on the national strategy of “healthy China” and the overall requirements of “three medical linkage” reform, and in accordance with the development objectives and business direction determined in the company’s strategic plan of “one body, two wings, two wheel drive, digital empowerment and healthy ecology”, taking digital medical insurance as the body, digital medical treatment and digital medicine as the two wings to build a basic platform, focusing on the comprehensive management services of medical insurance fund The three business directions of medical quality, hospital operation and management services and pharmaceutical machinery supervision services continuously promote mechanism innovation, deeply tap data value, actively carry out investment cooperation, realize the steady development of main business and the continuous improvement of overall operation.
During the reporting period, the company took the initiative to adapt to industry changes, focused on customer needs, promoted the upgrading of products and services, continued to build a series of products in the medical insurance field of “medical insurance accurate payment third-party services and big data intelligent monitoring services”, actively promoted the systematization of products and services, the specialization of business marketing, the standardization of delivery, operation and maintenance, and accelerated the implementation of the project, Focus on building project service model and continuously improve market share and industry influence.
Among the third-party services for accurate payment of medical insurance, disease diagnosis group (DRG) payment service, big data disease score (DIP) payment service and
The APG point method payment service has made full efforts in the year and blossomed at many points.
DRG business continues to expand its coverage. Among the regions that have implemented DRG payment reform in China, it has served more than 50 regions, and its market share remains in the lead.
The market share of dip business is also in the forefront. Among the regions implementing dip payment method in China, it has served more than 30 regions.
In terms of APG business, China Reform Health Management And Services Group Co.Ltd(000503) service Jinhua medical insurance bureau successfully launched APG outpatient payment, realized the business closed loop of payment mode reform, and was fully affirmed by the National Medical Insurance Bureau. At present, Jinhua APG has been promoted by Zhejiang Medical Insurance Bureau as the successful experience of pilot reform in the whole province. In terms of big data intelligent monitoring, we continued to promote the professional services of medical insurance fund audit and supervision, and actively promoted the implementation of big data intelligent monitoring business under the reform of DRG / Dip payment method. At present, the big data intelligent monitoring business has covered more than 200 regions in China.
In addition, the company actively carries out business development and product innovation. The business of direct insurance claims and quick insurance claims was steadily promoted. During the reporting period, a cooperation agreement was signed with Hangzhou health commission to create an application scenario of direct commercial insurance claim settlement service, and achieved good operational results. The prescription circulation business operated stably. During the reporting period, Wenzhou prescription circulation platform mode was connected with Wuzhong County in Ningxia and Anhui county, which was implemented as a practical matter for private people and reaped good social repercussions.
2、 China Reform Health Management And Services Group Co.Ltd(000503) in terms of digital medicine and digital medicine, how to promote the business to accelerate the expansion of market share?
A: China Reform Health Management And Services Group Co.Ltd(000503) in terms of digital medical business, we have further built core products such as hospital fine operation management system, medical quality control system, DRG / Dip hospital intelligent management system and intelligent medical record verification system. At present, it has covered more than 500 hospitals, including Nanjing Gulou Hospital, Zhejiang Provincial people’s Hospital and other leading hospitals. At the same time, accelerate the product layout to new fields such as outpatient APG intelligent management. Recently, new products such as outpatient APG intelligent management system and public hospital performance appraisal system have been released, gradually forming regional coverage advantages. Taking the leading hospitals in key regions as the benchmark, the trend of driving the rapid market coverage is taking shape. In addition, China Reform Health Management And Services Group Co.Ltd(000503) strengthened the market promotion, made a wonderful appearance at the third international medical quality and safety conference with a series of products, and released the VR exhibition hall of hospital business (19000 visitors in five days), which achieved good market results; Cooperation with ecological partners has also achieved certain results.
In terms of digital medicine business, during the year, it successfully obtained the secret related grade a software development qualification, continued to maintain its position advantage in the food and drug administration, covered the whole field, whole chain and whole process in the aspects of “Internet + e-government, drug and machinery supervision, quality traceability”, won the bid for the transformation project of the medical device approval system of the State Drug Administration, and the amount of individual projects exceeded ten million, a new record over the years. At the same time, in the key business application fields of intelligent supervision such as ERPs and variety archives, we continued to lead the development of the industry and won the bid for the construction of food traceability and supervision platform of Hunan market supervision administration, which is of great significance to open the gap and promote it in Hunan.
The company has accumulated experience in carrying out payment reform services in a large number of cities across the country. It is the first public company in China to realize the full coverage of “DRG + dip + APG” payment reform from outpatient to inpatient
With years of rich experience, knowledge and professional talent reserves, our services and products can provide all-round support services from the aspects of policy consultation, scheme design, parameter configuration, practical operation and so on. At the same time, the knowledge precipitation and experience accumulation formed in the service bureau side business play an important enabling role in the development of the company’s medical business and medical services.
3、 How can China Reform Health Management And Services Group Co.Ltd(000503) consolidate the basic market in digital medical insurance in 2021?
A: in 2021, the digital medical insurance business realized an operating revenue of 13737848612 yuan, an increase of 21.73% year-on-year. During the reporting period, the company focused on customers, sorted out existing products and services, continued to build a product series of “medical insurance accurate payment third-party service and big data intelligent monitoring service” in the field of medical insurance, actively promoted the systematization of product services, the specialization of business marketing and the standardization of delivery, operation and maintenance, accelerated the implementation of projects, focused on building project service models, and continuously improved market share and industry influence.
During the reporting period, we focused on consolidating the basic market from three aspects:
First, consolidate traditional business. Intelligent audit is China Reform Health Management And Services Group Co.Ltd(000503) ‘s traditional advantageous business. China Reform Health Management And Services Group Co.Ltd(000503) focuses on optimizing core knowledge assets such as intelligent audit rule base and clinical knowledge base to ensure that the core competitive advantage is leading in the industry. DRG / Dip payment method reform is an important basic business of China Reform Health Management And Services Group Co.Ltd(000503) company, giving full play to the first mover advantage, striving to improve service quality and service ability, forming industry reputation with customer recognition and continuously expanding business coverage; Optimize the market strategy, while promoting national coverage, focus on strengthening the overall coverage of key regional markets, especially winning the dip service of Henan Province, forming a benchmarking effect in Shandong and playing an important leading role in business expansion.
Second, continuous new business innovation. The industry was the first to launch the reform plan of outpatient APG payment method. On January 14, 2021, China Reform Health Management And Services Group Co.Ltd(000503) service Jinhua medical insurance bureau successfully launched the APG outpatient payment, realized the business closed loop of payment method reform, and was fully affirmed by the National Medical Insurance Bureau. Jinhua APG was promoted in Zhejiang Province as a pilot reform experience by Zhejiang Medical Insurance Bureau. While further consolidating China Reform Health Management And Services Group Co.Ltd(000503) ‘s leading position in the field of medical insurance payment method reform, It has opened up a new market of outpatient payment reform.
The third is to seize the medical insurance informatization business, actively comply with the national demand for deepening the reform of the medical security system and informatization construction, and increase the layout and expansion of the medical insurance informatization market. It has undertaken to build relevant subsystems of payment mode management and fund intelligent supervision in 9 provinces, including Guizhou, Hunan, Hubei, Anhui, Guangxi and Shandong, realizing continuous breakthroughs in the field of medical insurance informatization and laying a foundation for future business expansion and consolidation.
4、 Can the management describe the business development of digital medicine?
A: in 2021, the digital pharmaceutical business realized an operating revenue of 6275176107 yuan, a year-on-year increase of 14.22%. During the reporting period, the drug administration business continued to deepen and deepen, boosting the modernization of drug safety management. The pharmaceutical business department resolutely implemented the group strategy, promoted the comprehensive sharing of finance, personnel and administration, implemented regional management, focused on technology research and development and market expansion, and preliminarily established the development direction in line with its own technical and business characteristics. Successfully obtained the secret related grade a software development qualification, continued to maintain its advantages in the position of the food and drug administration, and made great progress in “Internet + e-government, drug and machinery supervision, and quality traceability”
Covering the whole field, whole chain and whole process, it won the bid for the transformation project of the medical device approval system of the State Drug Administration, and the amount of individual projects exceeded ten million,
